Entering text into the input field will update the search result below

Verastem Oncology appoints chief medical officer

  • Verastem (NASDAQ:VSTM) appoints of industry veteran Frank Neumann, M.D., Ph.D., as chief medical officer to oversee the company’s clinical and regulatory strategy and medical affairs team.
  • Appointment reflects progress of the company's RAS targeted therapy development program.
  • Company recently initiated registration-directed trials

Recommended For You

About VSTM Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VSTM--
Verastem, Inc.